C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 13, Issue 2, 2005, Pages 162-166

  Pantanowitz, Liron ^a,c   Schwartz, Erich J ^b   Dezube, Bruce J ^a   Kohler, Sabine ^b   Dorfman, Ronald F ^b   Tahan, Steven R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

c kit; Gleevec; Human herpesvirus 8; Imatinib; Immunohistochemistry; Kaposi sarcoma; Tyrosine kinase

Indexed keywords

PROTEIN LNA 1; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; CLINICAL ARTICLE; ENDEMIC DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR BIOPSY; VASCULAR TUMOR;

ADULT; HERPESVIRUS 8, HUMAN; HIV; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA, KAPOSI;

EID: 19444381517     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200506000-00009     Document Type: Article

References (26)

1. Schwartz EJ, Dorfman RF, Kohler S. Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma. An immunohistochemical study of 16 cases. Am J Surg Pathol. 2003;27:1546-1550.
2. Ensoli B, Sgadari C, Barillari G, et al. Biology of Kaposi's sarcoma. Eur J Cancer. 2001;37:1251-1269.
3. Moses AV, Jarvis MA, Raggo C, et al. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol. 2002;76:8383-8399.
4. Moses AV, Jarvis MA, Raggo C, et al. A functional genomics approach to Kaposi's sarcoma. Ann N Y Acad Sci. 2002;975:180-191.
5. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728-734.
6. Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol. 2000;13:536-541.
7. Pantanowitz L, Dezube BJ, Pinkus GS, et al. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol. 2004;31:26-34.
8. Heinrich MC, Blanke CD, Druker BJ, et al. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol. 2002;20:1692-1703.
9. th International Conference on Malignancies in AIDS and Other Immunodeficiencies. Bethesda, MD: National Institutes of Health; 2003:37.
10. Jacobs TW, Prioleau JE, Stillman IE, et al, Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996;88:1054-1059.
11. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 1994;424:135-141.
12. Vliagoftis H, Worobec AS, Metcalfe DD. The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol. 1997;100:435-440.
13. Taylor ML, Metcalfe DD. Kit signal transduction. Hematol Oncol Clin North Am. 2000;14:517-535.
14. Ashman LK. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol. 1999;31:1037-1051.
15. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, et al. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J. 1991;10:4121-4128.
16. Konig A, Corbacioglu S, Ballmaier M, et al. Downregulation of c-kit expression in human endothelial cells by inflammatory stimuli. Blood. 1997;90:148-155.
17. Cerimele F, Curreli F, Ely S, et al. Kaposi's sarcoma-associated herpes-virus can productively infect primary human keratinocytes and alter their growth properties. J Virol. 2001;75:2435-2443.
18. Miettinen M. Are desmoid tumors kit positive? Am J Surg Pathol. 2001;25:549-550.
19. Lucas DR, al-Abbadi M, Tabaczka P, et al. C-kit expression in desmoid fibromatosis. Comparative immunohistochemical evaluation of two commercial antibodies. Am J Clin Pathol. 2003;119:339-345.
20. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.
21. Russell Jones R, Orchard G, Zeiger B, et al. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol. 1995;48:1011-1016.
22. Broudy VC, Kovach NL, Bennett LG, et al. Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood. 1994;83:2145-2152.
23. Miyamoto T, Sasaguri Y, Sugama K, et al. Expression of the c-kit mRNA in human aortic endothelial cells. Biochem Mol Biol Int. 1994;34:513-520.
24. McCloskey KD, Hollywood MA, Thornbury KD, et al. Kit-like immunopositive cells in sheep mesenteric lymphatic vessels. Cell Tissue Res. 2002;310:77-84.
25. Hagiwara K, Khaskhely NM, Uezato H, et al. Mast cell " densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma. J Dermatol. 1999;26:577-586.
26. Heinrich MC, Rubin BP, Longley BJ, et al. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol. 2002;33:484-495.